Eton Pharmaceuticals, Inc. (ETON) stock
ETONNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30524% above fair value
$63.65−0.23 (-0.36%)
Close on Nov 17, 2026Market cap $1.82BP/E 163.2Yield –
Eton Pharmaceuticals operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Eton Pharmaceuticals's operating cash flow for the twelve months ending Jun 30, 2026 was $15.14M, up 23.7% year over year. For fiscal 2025 it was $10.52M, up 986.1% from the year before. The highest annual figure on record is $10.52M in fiscal 2025.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.52M | +986.1% |
| FY2024 | Dec 31, 2024 | $969.00K | -85.8% |
| FY2023 | Dec 31, 2023 | $6.82M | +41.4% |
| FY2022 | Dec 31, 2022 | $4.82M | – |
| FY2021 | Dec 31, 2021 | -$4.72M | – |
| FY2020 | Dec 31, 2020 | -$22.35M | – |
| FY2019 | Dec 31, 2019 | -$18.03M | – |
| FY2018 | Dec 31, 2018 | -$8.15M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $7.26M | -8.8% |
| Q1 FY2026 | Mar 31, 2026 | $7.41M | +254.3% |
| Q4 FY2025 | Dec 31, 2025 | -$11.55M | – |
| Q3 FY2025 | Sep 30, 2025 | $12.03M | +307.4% |
| Q2 FY2025 | Jun 30, 2025 | $7.96M | +534.2% |
| Q1 FY2025 | Mar 31, 2025 | $2.09M | – |
| Q4 FY2024 | Dec 31, 2024 | -$765.00K | -297.7% |
| Q3 FY2024 | Sep 30, 2024 | $2.95M | +238.1% |
| Q2 FY2024 | Jun 30, 2024 | $1.26M | -82.3% |
| Q1 FY2024 | Mar 31, 2024 | -$2.47M | – |
| Q4 FY2023 | Dec 31, 2023 | $387.00K | -86.4% |
| Q3 FY2023 | Sep 30, 2023 | $873.00K | – |
| Q2 FY2023 | Jun 30, 2023 | $7.10M | +188.6% |
| Q1 FY2023 | Mar 31, 2023 | -$1.55M | -226.6% |
| Q4 FY2022 | Dec 31, 2022 | $2.84M | – |
| Q3 FY2022 | Sep 30, 2022 | -$1.70M | – |
| Q2 FY2022 | Jun 30, 2022 | $2.46M | – |
| Q1 FY2022 | Mar 31, 2022 | $1.22M | -67.1% |
| Q4 FY2021 | Dec 31, 2021 | -$5.12M | – |
| Q3 FY2021 | Sep 30, 2021 | -$2.95M | – |
| Q2 FY2021 | Jun 30, 2021 | -$369.00K | – |
| Q1 FY2021 | Mar 31, 2021 | $3.72M | – |
| Q4 FY2020 | Dec 31, 2020 | -$7.18M | – |
| Q3 FY2020 | Sep 30, 2020 | -$5.09M | – |
| Q2 FY2020 | Jun 30, 2020 | -$2.85M | – |
| Q1 FY2020 | Mar 31, 2020 | -$7.22M | – |
| Q4 FY2019 | Dec 31, 2019 | -$3.85M | – |
| Q3 FY2019 | Sep 30, 2019 | -$3.22M | – |
| Q2 FY2019 | Jun 30, 2019 | -$4.20M | – |
| Q1 FY2019 | Mar 31, 2019 | -$6.77M | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.77M | – |
| Q3 FY2018 | Sep 30, 2018 | -$2.29M | – |
| Q2 FY2018 | Jun 30, 2018 | -$2.23M | – |
| Q1 FY2018 | Mar 31, 2018 | -$1.85M | – |
See a number that looks wrong?